MRI Guided Drug Delivery Market to Grow at 11.1% CAGR Through 2032 According to a newly published market research report by 24LifeSciences, global MRI Guided Drug Delivery market was valued at USD 103 million in 2024 and is projected to reach USD 212 million by 2032, growing at a compound annual growth rate (CAGR) of 11.1% during the forecast period 2025-2032. MRI guided drug delivery represents a transformative approach in precision medicine, utilizing magnetic resonance imaging to precisely target and release therapeutic agents at specific anatomical sites. This advanced technology combines real-time imaging with controlled drug release mechanisms, primarily leveraging High-Intensity Focused Ultrasound (HIFU) for non-invasive tissue ablation and targeted therapeutic delivery. The system enables temperature-sensitive drug carriers to release payloads when heated by focused ultrasound beams, while MRI provides continuous anatomical guidance and thermal monitoring, revolutionizing treatment approaches across multiple therapeutic areas. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/2152/mri-guided-drug-delivery-market

💠 Europe High-Intensity Focused Ultrasound (HIFU) Market Size & Forecast 2025–2033 Europe’s HIFU market is projected to rise from USD 35.04B in 2024 to USD 65.57B by 2033, growing at a strong CAGR of 7.21%. This growth is driven by increasing demand for non-invasive therapies, advancements in imaging technology, and rising cases of cancer and uterine fibroids across Europe. 🔗 Full Report: https://www.renub.com/europe-high-intensity-focused-ultrasound-hifu-market-p.php #HIFU #MedicalTechnology #HealthcareEurope #NonInvasiveTreatment #UltrasoundTherapy #MedicalDevices #MarketForecast #HealthcareTrends